Ani Pharmaceuticals (ANIP) Deferred Taxes (2014 - 2026)
Ani Pharmaceuticals (ANIP) posted Deferred Taxes of $2.5 million for Q1 2026, up 6.75% sequentially from $2.4 million in Q4 2025, and up 174.34% YoY from $916738.0 in Q1 2025.
Ani Pharmaceuticals (ANIP) Deferred Taxes (2014 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Deferred Taxes for 13 years, with the latest figure at $2.5 million in Q1 2026.
- Quarterly Deferred Taxes rose 174.34% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.1 million (up 170.9% YoY) and the FY2025 annual result came in at $14.2 million, up 164.97% from the prior year.
- Deferred Taxes rose to $2.5 million in Q1 2026 per ANIP's latest filing, from $2.4 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $18.8 million in Q3 2025 and troughed at -$17.5 million in Q4 2024.
- A 5-year average of -$1.9 million and a median of -$2.2 million in 2022 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2022 and 2025: Deferred Taxes plunged 2575.27% in 2022, then surged 436.44% in 2025.
- Over 5 years, Deferred Taxes stood at -$1.6 million in 2022, then slumped by 413.6% to -$8.3 million in 2023, then sank by 110.04% to -$17.5 million in 2024, then surged by 113.44% to $2.4 million in 2025, then grew by 6.75% to $2.5 million in 2026.
- According to Business Quant data, Deferred Taxes over the past three periods registered $2.5 million, $2.4 million, and $18.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.28 Bn | 165.89 Mn | -4.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.94 Mn |
| Mar 31, 2026 | 2.52 Mn |
| Dec 31, 2025 | 2.36 Mn |
| Sep 30, 2025 | 18.80 Mn |
| Jun 30, 2025 | -3.54 Mn |
| Mar 31, 2025 | -3.38 Mn |
| Dec 31, 2024 | -17.53 Mn |
| Sep 30, 2024 | -5.59 Mn |
| Jun 30, 2024 | -1.90 Mn |
| Mar 31, 2024 | 3.10 Mn |
| Dec 31, 2023 | -8.35 Mn |
| Sep 30, 2023 | -3.26 Mn |
| Jun 30, 2023 | -910,000.00 |
| Mar 31, 2023 | 773,000.00 |
| Dec 31, 2022 | -1.63 Mn |
| Sep 30, 2022 | -2.25 Mn |
| Jun 30, 2022 | -3.91 Mn |
| Mar 31, 2022 | -7.46 Mn |
| Dec 31, 2021 | -8.09 Mn |
| Sep 30, 2021 | -1.99 Mn |